Exercício 1 • You are offered an asset costing $600 that has cash fl ows of $100 at the end of each of the next 10 years. • a. If the appropriate discount rate for the asset is 8 percent, should you purchase it? • b. What is the IRR of the asset? Exercício 2 • You just took a $10,000, five-year loan. • Payments at the end of each year are flat (equal in every year) at an interest rate of 15 percent. Calculate the appropriate loan table, showing the breakdown in each year between principal
Words: 587 - Pages: 3
Q1. How should Printup go about segmenting the Metabical market? What do you think is the optimal target market? Segmentation Different segments as identified by Printup, based on different studies conducted can be classified as follows: • Psychographic segmentation It is based on a wide variety of attitudes towards physical activity, portion control, food preferences, nutrition, self-image, and overall health. Five discrete psychographic profiles identified in case of women can be classified
Words: 912 - Pages: 4
Marketing Assignment YP53B – Metabical Price M. Ray Akbar Mutalibov 29115113 For the case study of Metabical Price, I would recommend Option 2 ($125 in 4-week supply) as the price recommendation. This recommendation decision was mostly made of target return pricing, but combined with a little bit element of value-based pricing and psychological pricing. The reason I would choose the target return pricing as a main tools to pick the price is because the CSP’s Metabical informed us that they wanted
Words: 476 - Pages: 2
Metabical Pre-Launch Opportunity There is an opportunity to address a few potential issues in the upcoming marketing campaign for CSPs’ newest weight loss drug Metabical. CSP needs to be certain that we are addressing the right opportunities leading up to our launch. As the Director of Marketing I have been asked to present a brief overview identifying issues with our current launch strategy. The following report represents the area that has been identified as the biggest opportunity that we are
Words: 1396 - Pages: 6
20 anni di esperienza nel settore La compagnia è popolare negli Usa perchè la lanciato con esito altri farmaci ed altre campagne pubblicitarie ( Historico positivo) 2009 anno previsto del lancio del prodotto PROBLEMA: ESTRATEGIA VIABLE PER METABICAL SEGMENTAZIONE POSIZIONAMENTO MARKETING MIX CONTESTO: 65% popolazione è obesa = C’è UNA FORTE DOMANDA NEL MERCATO DI FARMACI PER PERDERE PESO Peso: problema sociale importante secondo due punti di vista: 1. STIGMATIZZAZIONE, DISCRIMINAZIONE
Words: 1325 - Pages: 6
Andrew Weeden, Jason Giest, Kerri Kuhn Group 12 Metabical Case Current Competition Metabical is the “first and only prescription weight loss drug to receive FDA approval.” This prescription drug has less side affects than current weight loss options, which creates a market niche because if people are not obese but want to lose 10-30 pounds they might consider it if the negative affects are subtle. CSP is targeting overweight people (BMI between 25 and 30) not obese or sever obese people (BMI
Words: 1464 - Pages: 6
success of Metabical product launch is critical to both CSP company and to the marketing director Printup. In order to achieve the long-term steady market goal, CSP need to identify their optimal target customer, appropriately position the Metabical product, and implement an efficient communication strategy. CSP should treat overweight women with BMI less than 30 at the age between 25 and 65 as their optimal target customer for the Metabical pill. Based on the product advantage, Metabical should be
Words: 1453 - Pages: 6
Obesity is a public health challenge throughout the world (1). Ongoing monitoring of trends in obesity is important to assess interventions aimed at preventing or reducing the burden of obesity. Since the 1960s, measured height and weight have been collected in the United States as part of the National Health and Nutrition Examination Survey (NHANES). In 2007–2008 more than one-third of United States adults were obese (2). Obese individuals are at increased risk of diabetes mellitus, cardiovascular
Words: 1641 - Pages: 7
What is the Decision-making process for Metabical? Who is involved in the process? Consumer research over the years has shown that shoppers often follow a relatively common shopping behavior for product purchase. In theory, a shopper is said to go through the following five stages as a process. In reality, sometimes the steps may be switched around or even left out, as not all consumers are by rule, always alike. The decision-making process (DMP) for Metabical, Cambridge Sciences Pharmaceuticals‘
Words: 3652 - Pages: 15
rP os t 4183 APRIL 14, 2010 JOHN A. QUELCH HEATHER BECKHAM op yo Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug In April 2008, after 10 years of testing and $400 million in research and development costs, Cambridge Sciences Pharmaceuticals’ (CSP) newest prescription drug, Metabical (pronounced Mehtuh-bye-cal), was about to receive its coveted Food and Drug Administration (FDA) approval. CSP was an international healthcare company with over
Words: 4511 - Pages: 19
